Your browser doesn't support javascript.
loading
Safety and Efficacy of Mini-Invasive Left Atrial Appendage Closure: A Propensity-Score Analysis.
Denis, Catherine; Clerfond, Guillaume; Chalard, Aurélie; Riocreux, Clément; Pereira, Bruno; Lamallem, Ouarda; Guizani, Taieb; Catalan, Pierre-Antoine; Boudias, Antoine; Jean, Frédéric; Bouchant-Pioche, Marion; Abu-Alrub, Saer; Combaret, Nicolas; Souteyrand, Géraud; Motreff, Pascal; Jabaudon, Matthieu; Futier, Emmanuel; Massoullie, Grégoire; Eschalier, Romain.
Afiliação
  • Denis C; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Clerfond G; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Chalard A; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Riocreux C; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Pereira B; Biostatistics Unit (Clinical Research and Innovation Direction), CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Lamallem O; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Guizani T; Department of Perioperative Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Catalan PA; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Boudias A; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Jean F; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
  • Bouchant-Pioche M; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Abu-Alrub S; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Combaret N; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Souteyrand G; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Motreff P; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Jabaudon M; Department of Perioperative Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France; iGReD, Université Clermont Auvergne, CNRS, INSERM, Clermont-Ferrand, France.
  • Futier E; Department of Perioperative Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France; iGReD, Université Clermont Auvergne, CNRS, INSERM, Clermont-Ferrand, France.
  • Massoullie G; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
  • Eschalier R; Cardiology Department, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France. Electronic address: reschalier@chu-clermontferrand.fr.
Can J Cardiol ; 2024 Apr 02.
Article em En | MEDLINE | ID: mdl-38570114
ABSTRACT

BACKGROUND:

Left atrial appendage closure (LAAC) for prevention of stroke is validated in patients with nonvalvular atrial fibrillation (NVAF) contraindicated to oral anticoagulation. General anaesthesia (GA) is often used for procedural guidance by transesophageal echocardiography (TEE); however, its use may be challenging in some patients. The aim of the study was to evaluate the safety and the midterm efficacy of a mini-invasive LAAC strategy using micro-TEE under procedural sedation.

METHODS:

Comparison by propensity score of 2 cohorts of consecutive patients who underwent LAAC standard TEE-guided LAAC (3-dimensional [3D] TEE under GA) and mini-invasive LAAC strategy (micro-TEE under procedural sedation). The primary endpoint was a composite of embolic or bleeding events, significant per procedural complication, and cardiovascular deaths within 3 months after LAAC.

RESULTS:

In total, 432 patients were included (78.7 ± 8 years old, 32.4% of women, CHA2DS2VASC score 4.9 ± 1.1); 127 patients underwent mini-invasive LAAC strategy and were compared with 305 patients standard TEE-guided LAAC. The mini-invasive strategy was achieved in 122 of 127 (96.1%) planned patients. The primary endpoint occurred in 11.2% of patients from the mini-invasive LAAC strategy group and in 10.3% of patients from the standard TEE group (absolute difference = 0.9% [-6.4; 4.5], hazard ratio = 1.11 [0.56; 2.19], P = 0.76). Procedural times, fluoroscopy duration, and hospital stays were shorter in the mini-invasive LAAC strategy group (P < 0.001).

CONCLUSIONS:

The mini-invasive LAAC strategy is safe and effective compared with the standard TEE-guided LAAC strategy. A mini-invasive LAAC strategy may also be an important tool to help physicians to treat more patients as LAAC indications evolve in the future.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Can J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Can J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França
...